High sensitive immunophenotyping and DNA ploidy techniques for minimal residual disease investigation in multiple myeloma.

被引：0
|
作者：
Almeida, J
Orfao, A
Ocqueteau, M
Mateo, G
Corral, M
Caballero, D
Blade, J
San Miguel, JF
机构：
[1] Univ Hosp, Hematol Serv, Dept Med, Univ Salamanca, Salamanca, Spain
[2] Hosp Clin, Barcelona, Spain
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
401
引用
收藏
页码：98A / 98A
页数：1
相关论文
共 50 条
  • [41] Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
    Flores-Montero, J.
    Sanoja-Flores, L.
    Paiva, B.
    Puig, N.
    Garcia-Sanchez, O.
    Boettcher, S.
    van der Velden, V. H. J.
    Perez-Moran, J-J
    Vidriales, M-B
    Garcia-Sanz, R.
    Jimenez, C.
    Gonzalez, M.
    Martinez-Lopez, J.
    Corral-Mateos, A.
    Grigore, G-E
    Fluxa, R.
    Pontes, R.
    Caetano, J.
    Sedek, L.
    del Canizo, M-C
    Blade, J.
    Lahuerta, J-J
    Aguilar, C.
    Barez, A.
    Garcia-Mateo, A.
    Labrador, J.
    Leoz, P.
    Aguilera-Sanz, C.
    San-Miguel, J.
    Mateos, M-V
    Durie, B.
    van Dongen, J. J. M.
    Orfao, A.
    LEUKEMIA, 2017, 31 (10) : 2094 - 2103
  • [42] Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
    J Flores-Montero
    L Sanoja-Flores
    B Paiva
    N Puig
    O García-Sánchez
    S Böttcher
    V H J van der Velden
    J-J Pérez-Morán
    M-B Vidriales
    R García-Sanz
    C Jimenez
    M González
    J Martínez-López
    A Corral-Mateos
    G-E Grigore
    R Fluxá
    R Pontes
    J Caetano
    L Sedek
    M-C del Cañizo
    J Bladé
    J-J Lahuerta
    C Aguilar
    A Bárez
    A García-Mateo
    J Labrador
    P Leoz
    C Aguilera-Sanz
    J San-Miguel
    M-V Mateos
    B Durie
    J J M van Dongen
    A Orfao
    Leukemia, 2017, 31 : 2094 - 2103
  • [43] Combined immunophenotyping and fluorescent in situ hybridisation is a sensitive technique for the detection of minimal residual disease
    OConnor, SJM
    Nacheva, E
    Green, AR
    BLOOD, 1995, 86 (10) : 2936 - 2936
  • [44] Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications
    Charalampous, Charalampos
    Kourelis, Taxiarchis
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [45] FLOW CYTOMETRIC ANALYSIS AND MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA: A COMPARISON BETWEEN FLOW CYTOMETRIC IMMUNOPHENOTYPING AND CYCLOSCOPE-MG.
    De Tullio, G.
    Ria, R.
    Reale, A.
    Minoia, C.
    Serrati, S.
    Loseto, G.
    Vacca, A.
    Guarini, A.
    HAEMATOLOGICA, 2013, 98 : 337 - 337
  • [46] Determination of Minimal Residual Disease in Multiple Myeloma: Does It Matter?
    Kothari, Shalin
    Hillengass, Jens
    McCarthy, Philip L.
    Holstein, Sarah A.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (01) : 39 - 46
  • [47] The role of minimal residual disease evaluation for patients with multiple myeloma
    Eun, Yoon Sang
    Kim, Hyun-Young
    Cho, Duck
    Kim, Seok Jin
    Kim, Kihyun
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S80 - S80
  • [48] Multiple myeloma patient perceptions of minimal residual disease testing
    Hydren, Jay
    Martinez, Jorge Arturo Hurtado
    Quiroz, Felipe Flores
    Perez, Patricia Alejandra Flores
    Espinoza, Andrea Isabel Robles
    Vicencio, Andrea Jimena Cuevas
    Flores, Marilu Najera
    Hernandez, Eduardo Franco
    Aldana, Ana Sahagun Sanchez
    Sweeney, Nathan
    Ahlstrom, Jennifer
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S74 - S74
  • [49] Progress in the application of minimal residual disease detection in multiple myeloma
    Xiaojia Zuo
    Dingsheng Liu
    Journal of Hematopathology, 2021, 14 : 97 - 107
  • [50] Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment
    Nishihori, Taiga
    Song, Jinming
    Shain, Kenneth H.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (02) : 118 - 126
12345